Assessment of myocardial viability by MR imaging

European Radiology

Volumn 13, Issue 1, 2003, Pages 52-61

  Sandstede, Jörn J W ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Heart; Ischemic heart disease; MR; Myocardial infarction; Myocardial viability

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PHOSPHORUS 31; SODIUM 23; THALLIUM 201; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INFARCTION; HEART MOVEMENT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; ARTICLE; FEMALE; HEART CONTRACTION; HEART MUSCLE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; CONTRAST MEDIA; DOBUTAMINE; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; SENSITIVITY AND SPECIFICITY;

EID: 0013272044     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-002-1701-y     Document Type: Review

References (46)

1. Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117:211-221
2. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M (1983) Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68:785-795
3. Pigott JD, Kouchoukos NT, Oberman A, Cutter GR (1985) Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 5:1036-1045
4. Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebisuzaki L (1995) Results of revascularization in patients with severe left ventricular dysfunction. Circulation 92:II73-II79
5. Kloner RA, Przyklenk K (1991) Hibernation and stunning of the myocardium. N Engl J Med 325:1877-1879
6. Kloner RA, Jennings RB (2001) Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Part 1. Circulation 104:2981-2989
7. Mallory GK, White PD, Salcedo-Salgar J (1939) The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases. Am Heart J 18:647-671
8. Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66:1146-1149
9. Bouchard A, Reeves RC, Cranney G, Bishop SP, Pohost GM (1989) Assessment of myocardial infarct size by means of T2-weighted 1H nuclear magnetic resonance imaging. Am Heart J 117:281-289
10. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U (1995) Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with 18F-fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myodardial viability. Circulation 91:1006-1015
11. Sandstede J, Bertsch G, Beer M, Kenn W, Werner E, Pabst T, Lipke C, Kretschmer S, Neubauer S, Hahn D (1999) Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 17:1437-1443
12. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, Erdmann E (1998) Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31:1040-1048
13. Gunning MG, Anagnostopoulos C, Knight CJ, Pepper J, Burman ED, Davies G, Fox KM, Pennell DJ, Ell PJ, Underwood SR (1998) Comparison of 201T1, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 98:1869-1874
14. De Roos A, Doornbos J, van der Wall EE, van Voorthuisen AE (1988) MR imaging of acute myocardial infarction: value of Gd-DTPA. Am J Roentgenol 150:531-534
15. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215-223
16. Saeed M, Higgins CP, Geschwind JF, Wendland MF (2000) T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echoplanar MR imaging. Eur Radiol 10:310-318
17. Diesbourg LD, Prato FS, Wisenberg G, Drost DJ, Marshall TP, Carroll SE, O'Neill B (1992) Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 23:239-253
18. Inoue S, Murakami Y, Ochiai K, Kitamura J, Ishibashi Y, Kawamitsu H, Sugimura K, Shimada T (1999) The contributory role of interstitial water in Gd-DTPA-enhanced MRI in myocardial infarction. J Magn Reson Imaging 9:215-219
19. Rehwald WG, Fieno DS, Chen E-L, Kim RJ, Judd RM (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105:224-229
20. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM (2000) Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102:1678-1683
21. Kim RJ, Chen EL, Lima JA, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318-3326
22. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Roisille P, Lima JAC, Mohan V, Becker LC, Zerhouni EA (1995) Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92:1902-1910
23. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002
24. Rochitte CE, Lima JAC, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA (1998) Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 98:1006-1014
25. Sandstede J, Lipke C, Beer M, Harre K, Pabst T, Kenn W, Neubauer S, Hahn D (2000) Analysis of first-pass and delayed MRI contrast enhancement patterns of dysfunctional myocardium for the prediction of myocardial viability. Am J Roentgenol 174:1737-1740
26. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445
27. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM (2001) Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104:1101-1107
28. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann HJ, Higgins CB (2001) Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 103:871-876
29. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA (2001) Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 104:2838-2842
30. Rogers WJ Jr, Kramer CM, Geskin G, Hu YL, Theobald TM, Vido DA, Petruolo S, Reichek N (1999) Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 99:744-750
31. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, Hu YL (2000) Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 36:1835-1840
32. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA (1995) Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92:1117-1125
33. Kloner RA, Ganote CE, Jennings RB (1974) The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496-1508
34. Dendale P, Franken PR, Bolck P, Pratikakis Y, de Roos A (1998) Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 135:875-880
35. Sandstede J, Beer M, Lipke C, Pabst T, Kenn W, Harre K, Neubauer S, Hahn D (2001) Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability. J Magn Reson Imaging 14:789-794
36. Wu KC, Zerhouni EA, Judd RM, Lugo OCH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765-772
37. Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE, Ugurbil K, McDonald K, Wilson RF (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373-384
38. von Kienlin M, Beer M, Greiser A, Hahn D, Harre K, Kostler H, Landschütz W, Pabst T, Sandstede J, Neubauer S (2001) Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications. J Magn Reson Imaging 13:521-527
39. Yabe T, Mitsunami K, Inubushi T, Kinoshita M (1995) Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation 92:15-23
40. Beer M, Sandstede J, Landschütz W, Viehrig M, Harre K, Horn M, Meininger M, Pabst T, Kenn W, Haase A, von Kienlin M, Neubauer S, Hahn D (2000) Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans. Eur Radiol 10:1323-1328
41. Meininger M, Landschutz W, Beer M, Seyfarth T, Horn M, Pabst T, Haase A, Hahn D, Neubauer S, von Kienlin M (1999) Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy. Magn Reson Med 41:657-663
42. Pohmann R, von Kienlin M (2001) Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med 45:817-826
43. Sandstede J, Pabst T, Beer M, Lipke C, Bäurle K, Butter F, Harre K, Kenn W, Voelker W, Neubauer S, Hahn D (2001) 23Na magnetic resonance imaging for the assessment of myocardial infarction in humans: comparison with cine MRI and delayed contrast enhancement. Radiology 221:222-228
44. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM (1997) Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 30:1451-1460
45. Baumgartner H, Porenta G, Lau YK, Wutte M, Klaar U, Mehrabi M, Siegel RJ, Czernin J, Laufer G, Sochor H, Schelbert H, Fishbein MC, Maurer G (1998) Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol 32:1701-1708
46. Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, deVivie ER, Schicha H, Erdmann E, Sechtem U (1996) Predictive value of low dose dobutamine transesophageal echocardiography und fluorine 18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 28:60-69